期刊文献+

B型利钠肽水平与老年慢性心力衰竭的相关性分析

The Correlative Study of B-type Natriuretic Peptide and The Aged Patients with Chronic Heart Failure
在线阅读 下载PDF
导出
摘要 目的探讨B型利钠肽(BNP)水平和老年慢性心力衰竭之间的相关性。方法选取来我院就诊的确诊为慢性心力衰竭的老年患者127例,抽取其静脉血采用酶联免疫吸附法检测患者BNP水平,用统计学方法分析各心功能分级组别的BNP水平。结果各个心功能分级组别间患者年龄比较差异均有统计学意义(P<0.05),且患者的年龄随着心功能分级的升高而增大;各组间BNP水平比较,均有极显著性差异,且心功能分级越高,患者的年龄越大,BNP水平越高(P<0.01)。结论 B型脑钠肽的水平与HYHA分级呈正相关,能够预示慢性心衰患者病情的严重程度,客观地反映心功能的情况,在临床上对慢性心力衰竭患者病情的诊断及危险分级具有积极的意义。 Objective To observe and study the correlative of B -type Natriuretic Peptide and the aged patients with chronic heart failure. Methods 127 aged patients with chronic heart failure were collected from Zhongshan hospital, the BNP levels was analyzed by enzymelinked immunosorbent assays ( ELISA ). And the analytical method of BNP in every cardiac function class was statistics analysis. Results There was a significant difference on the age of every cardiac function class ( P 〈 0.05 ) ; The age was significantly increased with the severity of cardiac function classification. There was a significant difference on the BNP level in every group. The age was higher and the BNP level was higher, with the severity of cardiac function classification ( P 〈 0.01 ). Conclusion BNP level was positive with cardiac function classification. It can reflect the station of cardiac function, and have positive significance of diagnosis and classification on the patients with chronic heart failure.
作者 朱圣文
出处 《中国现代医生》 2011年第21期117-118,共2页 China Modern Doctor
关键词 B型利钠肽 慢性心力衰竭 心功能分级 B-type natriuretic peptide Chronic heart failure Cardiac function classification.
  • 相关文献

参考文献10

二级参考文献25

  • 1马苏亚.Tei指数——综合评价心脏收缩与舒张功能的新指标[J].现代实用医学,2006,18(1):5-7. 被引量:8
  • 2高晓军,王洪霞,纪宗萍.Tei指数在检测左室舒张功能假性正常化中的意义[J].中国医师进修杂志(内科版),2006,29(3):50-51. 被引量:5
  • 3赵雪燕,杨跃进,张健,党爱民,倪新海,黄洁,康晟,马卫华,赵冬云.B型利钠肽在诊断左心衰竭中的价值[J].中华医学杂志,2006,86(17):1165-1169. 被引量:97
  • 4吕先光,刘朝中.B-型利尿钠肽在冠心病所致慢性充血性心力衰竭的诊断、治疗和愈后评估中的作用[J].现代生物医学进展,2007,7(6):930-933. 被引量:24
  • 5Dickstein K. Natriuretic peptides in detection of heart failure. Lancet, 1998,35:3-4.
  • 6Groenning BA, Nilsson JC, Sondergaard L, et al. Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations. European Journal of Heart Failure, 2001,3:699-708.
  • 7Selvais PL, Donckier JE, Robert A, et al. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure; influences of left ventricular dysfunction and coronary artery disease on c ardiac hormonal activation. Eur J Clin Invest,1998,28:636-642.
  • 8Clerio A, Lervasi G, Chicca M, et aL Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in nornal subjects and in patients with different degrees of heart failure. J Endocrinol Invest, 1998, 21:170-179.
  • 9Luchner A, Stevents TL, Borgeson DD, et al. Differential atria and ventricular expression of myocardial BNP during evolution of heart failure. Am J Physionl, 1998, 274:H1684-1689.
  • 10Maeda K, Takayoshi T, Wada A, et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolicpressure in patients with symptomatic left ventricular dysfunction. Am Heart J, 1998, 135:825-832.

共引文献2436

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部